These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10417435)

  • 21. Treatment of cutaneous larva migrans.
    Caumes E
    Clin Infect Dis; 2000 May; 30(5):811-4. PubMed ID: 10816151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous larva migrans in infants in the Adelaide Hills.
    Black MD; Grove DI; Butcher AR; Warren LJ
    Australas J Dermatol; 2010 Nov; 51(4):281-4. PubMed ID: 21198527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis.
    Singthong S; Intapan PM; Wongsaroji T; Maleewong W
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():32-4. PubMed ID: 17547048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creeping eruption of larva migrans--a case report in a beach volley athlete.
    Biolcati G; Alabiso A
    Int J Sports Med; 1997 Nov; 18(8):612-3. PubMed ID: 9443594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial.
    Singhi P; Dayal D; Khandelwal N
    Pediatr Infect Dis J; 2003 Mar; 22(3):268-72. PubMed ID: 12634590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rare case of cutaneous larva migrans due to Gnathostoma sp.
    Mukherjee A; Ahmed NH; Samantaray JC; Mirdha BR
    Indian J Med Microbiol; 2012; 30(3):356-8. PubMed ID: 22885209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral albendazole for the treatment of cutaneous larva migrans.
    Jones SK; Reynolds NJ; Oliwiecki S; Harman RR
    Br J Dermatol; 1990 Jan; 122(1):99-101. PubMed ID: 2297509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Creeping eruption.
    Yap FB
    Int J Infect Dis; 2010 Jun; 14(6):e545. PubMed ID: 19889564
    [No Abstract]   [Full Text] [Related]  

  • 29. [Larva migrans].
    Chabasse D; Le Clec'h C; de Gentile L; Verret JL
    Sante; 1995; 5(6):341-5. PubMed ID: 8784535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous larva migrans (hookworm) acquired in Christchurch, New Zealand.
    Manning L; Chambers S; Paltridge G; Maurice P
    N Z Med J; 2006 Mar; 119(1231):U1910. PubMed ID: 16582972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S1 guideline diagnosis and therapy of cutaneous larva migrans (creeping disease).
    Sunderkötter C; von Stebut E; Schöfer H; Mempel M; Reinel D; Wolf G; Meyer V; Nast A; Burchard GD
    J Dtsch Dermatol Ges; 2014 Jan; 12(1):86-91. PubMed ID: 24393321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hookworm-related cutaneous larva migrans: albendazole or ivermectin?].
    Vanhaecke C; Caumes É
    Ann Dermatol Venereol; 2012; 139(8-9):518-20. PubMed ID: 22963959
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller.
    Blackwell V; Vega-Lopez F
    Br J Dermatol; 2001 Sep; 145(3):434-7. PubMed ID: 11531833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-day versus 15-day course of albendazole therapy in solitary cysticercus granuloma: an open label randomized trial.
    Khurana N; Garg RK; Verma R; Malhotra HS; Singh MK; Shukla R
    J Neurol Sci; 2012 May; 316(1-2):36-41. PubMed ID: 22342396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of eosinophilic meningitis with a combination of albendazole and corticosteroid.
    Chotmongkol V; Wongjitrat C; Sawadpanit K; Sawanyawisuth K
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):172-4. PubMed ID: 15272765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and outcomes of patients with diffuse unilateral subacute neuroretinitis treated with oral albendazole.
    Souza EC; Casella AM; Nakashima Y; Monteiro ML
    Am J Ophthalmol; 2005 Sep; 140(3):437-445. PubMed ID: 16026752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Case of Toxocara canis larva migrans cured by additional treatment with albendazole].
    Takamatsu K; Sumitani M; Nanjyou S; Nishijima M; Syoji S; Takifuji N; Kiyota H; Daga H; Takeda K
    Nihon Kokyuki Gakkai Zasshi; 2008 Oct; 46(10):836-41. PubMed ID: 19044036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of cutaneous ancylostoma larva migrans].
    Caumes E; Gentilini M
    Ann Dermatol Venereol; 1993; 120(8):571-3. PubMed ID: 8304718
    [No Abstract]   [Full Text] [Related]  

  • 39. Albendazole in the treatment of strongyloidiasis.
    Pungpak S; Bunnag D; Chindanond D; Radmoyos B
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):207-10. PubMed ID: 3672182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of eosinophilia with albendazole.
    Insiripong S; Siriyakorn N
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):517-20. PubMed ID: 18564693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.